Archives

by in
Entry Author Date Location
Astellas Tells Aveo to Go It Alone in Kidney Cancer 05/24/13 Boston
Wireless Health Summit Looks to “Engaged Consumer” to Drive Change 05/24/13 San Diego
Merrimack Aims For Penny-Wise Pipeline of Cancer Drugs 05/24/13 Boston
San Diego Life Sciences Roundup: Effector, Ignyta, and More 05/23/13 San Diego
Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections 05/22/13 Seattle
Ironwood, NPS Pharma Tap Wall Street To Roll Out Lead Drugs 05/22/13 Boston
Regeneron Eyes Potential Blockbuster With Asthma Drug 05/21/13 New York
Kineta, Scouring the World for Cash, Finds Oil Money 05/21/13 Seattle
Effector Therapeutics Raises $45M to Prove New Concept in Cancer 05/21/13 San Diego
Juan Enriquez on the Forces Shaping Innovation: A Napa Summit Preview 05/21/13 National
Karyopharm Grabs $48.2M Series B to Advance Cancer Drugs 05/20/13 Boston
NanoString Technologies Maneuvers In Line for $86M IPO 05/20/13 Seattle
Accelerate LI’s Lofty Goal: Create the Next U.S. Innovation Cluster 05/20/13 New York
Zillions of Biotech Conferences Want You. Which Should You Attend? 05/20/13 National
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients 05/17/13 Texas
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More 05/17/13 San Diego
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Check KUOW’s “Weekday” for Science News 05/17/13 Seattle
San Diego’s AnaptysBio Gets BioDefense Contract for Ricin Antibodies 05/16/13 San Diego
Ambit Slices Price of IPO, Increases Number of Shares Offered 05/16/13 San Diego
Matrix Genetics Emerges from Algae Biofuel Wilderness With a Partner 05/16/13 Seattle
Bellicum in Trials with Cancer Vaccine, Cell-Suicide Switches 05/16/13 Texas
San Diego’s RuiYi (aka Anaphore) Focuses Anew on Antibodies & China 05/16/13 San Diego
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Genentech Follows Fast at ASCO as Cancer Immunotherapy Picks Up 05/15/13 San Francisco
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study 05/15/13 San Francisco
Why the Kendall Square Lab and Office Markets Are Out of Whack 05/15/13 Boston
Gradalis’s Fang Bares Its Teeth in Fighting Ovarian Cancer 05/15/13 Texas
Hollywood Celebrates Breast Cancer Genetics Pioneer Mary-Claire King 05/15/13 Seattle
OSI Pharma, Long Island Biotech Bellwether, Shut Down by Astellas 05/14/13 New York
Page 3 of 216 « previous page · next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.